Remove Product-innovations Technical-Papers
article thumbnail

EMA urges “human-centric approach” to AI in drug discovery

Drug Discovery World

The EMA has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of medicines. The reflection paper highlights that a human-centric approach should guide all development and deployment of AI and ML.

Drugs 40
article thumbnail

Taking steps towards a data-driven future for health and social care

pharmaphorum

A new policy paper promises to make it easier for innovators and developers to build and deploy tech and AI solution. The document also talks about improving data for adult social care, ensuring researchers have the data they need, and helping developers and innovators to improve health and care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer to Present Latest Scientific Advancements from Its Industry-Leading Portfolio at the ESMO Virtual Congress 2020

The Pharma Data

Meaningful innovation in cancer care requires building upon our understanding of tumor biology, leveraging cutting-edge research, and applying the knowledge we gain into new treatments that address and prevent resistance,” said Chris Boshoff, M.D., Chief Development Officer, Oncology, Pfizer Global Product Development. “We Mayer E. .

article thumbnail

Leveraging Tableau for Real-Time Signal Management Solution for Drug Safety and Efficacy

Cloudbyz

This paper will explore the benefits of leveraging Tableau for real-time signal management for drug safety and efficacy and provide guidance on how to effectively use Tableau in this context. Easy-to-Use Interface: Tableau has an intuitive interface that is easy to use, even for those with limited technical skills.

Drugs 52
article thumbnail

GSK Consumer Healthcare commits to make over a billion toothpaste tubes recyclable by 2025 as part of its ongoing sustainability journey

The Pharma Data

We have made the commitment that 100% of our product packaging will be recyclable or reusable, where quality and safety permits, by 2025.This It is now collaborating with retailers and dental healthcare professionals to drive the growth of more sustainable options in oral care products across the world. Best’ in Germany.

article thumbnail

Keeping clinical trial data safe – handling cybersecurity in a risky world

pharmaphorum

These trends combine to increase the pace of innovation and the precision of therapies. Leading academic research institutions and pharma/biopharma players exploring therapeutic areas such as immuno-oncology or cell and gene therapy no longer start ‘analogue only’ projects because of time and productivity shortcomings.

article thumbnail

Expert view: What’s next for cell and gene therapy?

Drug Discovery World

What are the global innovations in cell and gene therapy? The deeper the understanding of product and process from a characterisation standpoint, the smoother the regulatory conversations and development pathway will be.” However, ATMPs are highly personalised medicines whose productions often need to be tailored to each patient.